WillItSurvive
YC Winter 2026 · United States

ClaimGlide

AI tool that drafts and files prior authorizations for private medical practices.

Protection under test
Assessed 27 July 2026 · Evidence as of 27 July 2026
Something worth protecting exists and is being tested right now.
On the recordSince 27 July 2026 · Checkable from late 2026 to 2027 · Every call on the record Checkpoint: CMS final rule on CMS-0062-P (drug prior-auth interoperability) after June 15, 2026 comment close
The call

ClaimGlide is a new, AI-native prior-auth tool sitting between well-funded AI rivals and EHR giants that could build the same feature themselves.

ClaimGlide makes software that uses artificial intelligence to write prior authorization requests (paperwork doctors need to get insurance approval before treatment) and appeals when insurers say no. The problem is that bigger, well-funded companies and the companies that run doctor's electronic health records are building the same thing, and they can do it cheaper or bundle it free with their existing software that doctors already use every day.

Why
01
AI pressure: Silna, Anterior, Myndshft and other funded AI prior-auth startups. Frontier LLMs make PA drafting and appeals easy to copy, so better-funded AI rivals can build the same thing faster. Could AI do the core job? Yes, likely.
02
Bigger players: athenahealth, eClinicalWorks, NextGen, ModMed. These EHR vendors already hold the patient record and could bundle native AI prior-auth into their platforms, cutting out third-party tools like ClaimGlide. Could a giant copy it? Yes, easily.
03
What protects it. No protection yet documented; only a future specialty focus with its own payer-approval data and clinical distribution could create one.
What would change this call
athenahealth or eClinicalWorks ships native bundled AI prior-auth features. Would remove the need for a separate third-party tool like ClaimGlide.
ClaimGlide announces a specialty focus (e.g. infusion, ortho, GI) with a payer-approval dataset. Would show it is building a defensible niche instead of staying a generalist.
Silna Health, Cohere Health, or Myndshft announce new funding or move down-market to independent practices. Would show rivals locking up the small-practice distribution ClaimGlide targets.
Key numbers
  • CMS-0057-F cut PA decision time to 7 days (72hr expedited) (2026-01-01)
  • CMS-0062-P comment period closed June 15, 2026 (2026-06-15)
  • Rival AI prior-auth startups raised $25M-$90M combined (2026)
Named risks
  • No proprietary data, exclusive integrations, or documented moat versus funded rivals in a crowded market. Severity: high
  • EHR vendors like athenahealth and eClinicalWorks could bundle native AI prior-auth features within 18-24 months, commoditizing ClaimGlide's core product. Severity: high
  • No public revenue, pricing, customer, or funding figures disclosed, raising uncertainty about post-Demo Day survival. Severity: medium
  • State-level bills restricting automated AI in payer PA decisions signal a tightening regulatory environment for AI in this workflow. Severity: low
  • Location and founding details conflict across sources (Seattle vs San Francisco), suggesting limited public verification of basic company facts. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
Silna Healthlosing toRaised approximately $27M in 2025 and reports 50,000+ patients supported in specialty/infusion PA niche
Cohere Healthlosing toRaised $90M Series C in 2025 and acquired ZignaAI for payer-side surgical/MSK PA
Anteriorlosing toRaised $40M in early 2026 from NEA and Sequoia, total ~$64M, payer-side clinical review AI
Myndshftlosing toClaims rules engine spanning 600+ payers versus ClaimGlide's 4 named EHR integrations, 2026-06-14
athenahealthcontestingExpanded AI-native revenue cycle management features including athenaPayer PA tools, announced 2026-06-03
eClinicalWorkscontestingNamed as a ClaimGlide integration partner but also positioned as a potential native PA bundler by EHR vendors
Questions people ask
Is ClaimGlide profitable in 2026?
No revenue, customer counts, or profitability figures for ClaimGlide have been made public. As a Y Combinator Winter 2026 batch company, it is pre-traction or has not yet disclosed traction data as of July 27, 2026, per its YC company profile.
Could AI replace ClaimGlide's product?
ClaimGlide's own product, LLM-drafted prior-auth submissions and appeal letters, is itself the kind of task frontier models and RAG over payer policy documents commoditize natively, meaning better-funded rivals or EHR vendors could replicate it within 18 to 24 months.
Who is ClaimGlide's biggest competitor?
ClaimGlide competes with funded rivals like Silna Health (~$27M raised, 2025), Cohere Health ($90M Series C, 2025), and Anterior (~$64M total, early 2026), plus EHR vendors like athenahealth and eClinicalWorks that could bundle native prior-auth automation.
Who owns ClaimGlide?
ClaimGlide is privately held and founded by Nami Lindquist, a University of Pennsylvania M&T undergraduate from Bellevue, WA. It is part of Y Combinator's Winter 2026 batch; no outside investors or valuation have been publicly confirmed as of July 27, 2026.
Does ClaimGlide have a moat against bigger rivals?
No proprietary payer-approval dataset, exclusive EHR integrations, or regulatory advantage beyond stated HIPAA compliance has been documented for ClaimGlide as of July 21, 2026, per apis.io, while rivals like Myndshft claim coverage across 600 plus payers.
Where is ClaimGlide headquartered?
Sources conflict: apis.io states ClaimGlide was founded in 2025 in Seattle, while a PitchBook profile lists San Francisco as headquarters. As of July 27, 2026, this location discrepancy remains unresolved in public sources.
Timeline
  • 2026-06-17CB Insights covers ClaimGlide as part of YC Winter 2026's most technically complex cohort
  • 2026-06-14CMS proposed rule CMS-0062-P comment period on drug prior-auth interoperability closes
  • 2026-06-03athenahealth announces expanded AI-native revenue cycle management features in athenaOne
  • 2026-06-02ClaimGlide confirmed as member of YC Winter 2026 batch of roughly 199-200 companies
  • 2026-04-14CMS publishes proposed rule CMS-0062-P extending PA interoperability standards to drugs
  • 2026-03-12YC W26 batch commentary references approaching Demo Day for cohort including ClaimGlide
  • 2026-01-01CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) takes effect, 7-day PA decisions
  • 2025-12-22athenahealth publishes blog on athenaPayer modernizing prior authorization
  • 2025ClaimGlide founded, per apis.io company profile
  • 2023-07-21Founder Nami Lindquist publishes Substack post on financing entrepreneurial ventures
Revision history
27 July 2026
First assessed. Protection under test. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources